Product Information
GLYCOPYRROLATE 2 MG TABLET is a generic product labeled by Endo USA Inc., priced at $0.1481 per EA under NDC 49884006601. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Aug 31, 2006. Its Orange Book therapeutic-equivalence code is AA.
Strength
2 mg/1
Manufacturer
Endo USA Inc.NDC
49884006601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GLYCOPYRROLATEApproval Type
Generic (ANDA)
FDA Application
ANDA040653FDA Approved
8/31/2006
TE Code
AA
On Market Since
9/26/2006
Pharmacological Classes
Price Statistics
The NADAC for GLYCOPYRROLATE 2 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 80.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1481 per EA |
|---|---|
| All-time high | $0.7963 (Mar 12, 2014) |
| All-time low | $0.1444 (Nov 20, 2024) |
| 52-week high | $0.2419 |
| 52-week low | $0.1462 |
| Median price | $0.3690 |
| Average price | $0.3954 |
| Largest weekly change | +80.0% (Feb 23, 2022) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the glycopyrrolate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Endo USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
glycopyrrolate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLYCOPYRROLATE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLYCOPYRROLATE 2 MG TABLET, manufactured by Endo USA Inc., is $0.1481 per EA (NDC 49884006601), effective Sep 30, 2026.
How has the price of GLYCOPYRROLATE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLYCOPYRROLATE 2 MG TABLET has declined 80.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLYCOPYRROLATE 2 MG TABLET?
Since Nov 28, 2013, the NADAC for GLYCOPYRROLATE 2 MG TABLET has ranged from a low of $0.1444 (Nov 20, 2024) to a high of $0.7963 (Mar 12, 2014), with a median of $0.3690 per EA.
Are there cheaper alternatives to GLYCOPYRROLATE 2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of GLYCOPYRROLATE 2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GLYCOPYRROLATE 2 MG TABLET?
GLYCOPYRROLATE 2 MG TABLET (NDC 49884006601) is labeled by Endo USA Inc., and CMS classifies it as a generic product.